Literature DB >> 9819396

Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.

O Kustikova1, D Kramerov, M Grigorian, V Berezin, E Bock, E Lukanidin, E Tulchinsky.   

Abstract

Two cell lines originating from a common ancestral tumor, CSML0 and CSML100, were used as a model to study AP-1 transcription factors at different steps of tumor progression. CSML0 cells have an epithelial morphology; they express epithelial but not mesenchymal markers and are invasive neither in vitro nor in vivo. CSML100 possesses all characteristics of a highly progressive carcinoma. These cells do not form tight contacts, are highly invasive in vitro, and are metastatic in vivo. AP-1 activity was considerably higher in CSML100 cells than in CSML0 cells. There was a common predominant Jun component, namely, JunD, detected in both cell lines. We found that the enhanced level of AP-1 in CSML100 cells was due to high expression of Fra-1 and Fra-2 proteins, which were undetectable in CSML0 nuclear extracts. Analysis of the transcription of different AP-1 members in various cell lines derived from tumors of epithelial origin revealed a correlation of fra-1 expression with mesenchymal characteristics of carcinoma cells. Moreover, we show here for the first time that the expression of exogenous Fra-1 in epithelioid cells results in morphological changes that resemble fibroblastoid conversion. Cells acquire an elongated shape and become more motile and invasive in vitro. Morphological alterations were accompanied by transcriptional activation of certain genes whose expression is often induced at late stages of tumor progression. These data suggest a critical role of the Fra-1 protein in the development of epithelial tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819396      PMCID: PMC109291          DOI: 10.1128/MCB.18.12.7095

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  85 in total

1.  Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins.

Authors:  D Mumberg; F C Lucibello; M Schuermann; R Müller
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

Review 2.  Role of intermediate filaments in migration, invasion and metastasis.

Authors:  M J Hendrix; E A Seftor; Y W Chu; K T Trevor; R E Seftor
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

3.  Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of AP1 activity.

Authors:  P Pognonec; K E Boulukos; C Aperlo; M Fujimoto; H Ariga; A Nomoto; H Kato
Journal:  Oncogene       Date:  1997-05-01       Impact factor: 9.867

4.  Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.

Authors:  D W Bahler; E M Lord; S J Kennel; P K Horan
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

5.  The jun and fos protein families are both required for cell cycle progression in fibroblasts.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

6.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation.

Authors:  K A Lord; A Abdollahi; B Hoffman-Liebermann; D A Liebermann
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

8.  Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.

Authors:  E Lengyel; H Wang; E Stepp; J Juarez; Y Wang; W Doe; C M Pfarr; D Boyd
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

9.  Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.

Authors:  P S Walmod; A Foley; A Berezin; U Ellerbeck; H Nau; E Bock; V Berezin
Journal:  Cell Motil Cytoskeleton       Date:  1998

10.  The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion.

Authors:  M Ringwald; R Schuh; D Vestweber; H Eistetter; F Lottspeich; J Engel; R Dölz; F Jähnig; J Epplen; S Mayer
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  61 in total

1.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

2.  The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.

Authors:  K Belguise; S Milord; F Galtier; G Moquet-Torcy; M Piechaczyk; D Chalbos
Journal:  Oncogene       Date:  2012-01-30       Impact factor: 9.867

3.  Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip.

Authors:  Bo Song; Jian-Wu Tang; Bo Wang; Xiao-Nan Cui; Li Hou; Lu Sun; Li-Min Mao; Chun-Hui Zhou; Yue Du; Li-Hui Wang; Hua-Xin Wang; Ren-Shu Zheng; Lei Sun
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Critical regulation of genes for tumor cell migration by AP-1.

Authors:  El Mustapha Bahassi; Saikumar Karyala; Craig R Tomlinson; Maureen A Sartor; Mario Medvedovic; Robert F Hennigan
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.

Authors:  Heather J Spence; Lynn McGarry; Catherine S Chew; Neil O Carragher; Linda A Scott-Carragher; Zhengqiang Yuan; Daniel R Croft; Michael F Olson; Margaret Frame; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.

Authors:  L Oliveira-Ferrer; M Kürschner; V Labitzky; D Wicklein; V Müller; G Lüers; U Schumacher; K Milde-Langosch; C Schröder
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-10       Impact factor: 4.553

7.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

8.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

9.  HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

Authors:  Maria E Ramos-Nino; Steven R Blumen; Tara Sabo-Attwood; Harvey Pass; Michele Carbone; Joseph R Testa; Deborah A Altomare; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-13       Impact factor: 6.914

10.  Prognostic significance of loss of c-fos protein in gastric carcinoma.

Authors:  Seon Pil Jin; Ji Hun Kim; Min A Kim; Han-Kwang Yang; Hee Eun Lee; Hye Seung Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.